相似文献
1
[Oral Crohn disease. Apropos of a case].
Rev Stomatol Chir Maxillofac. 1997 Dec;98(5):299-302.
2
Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Clin Gastroenterol Hepatol. 2003 Mar;1(2):122-8. doi: 10.1053/cgh.2003.50015.
3
Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Eur J Surg. 1998 Dec;164(12):903-9. doi: 10.1080/110241598750005066.
4
Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Rev Gastroenterol Disord. 2002;2 Suppl 2:S9-15.
5
Crohn's disease and acute leukocytoclastic vasculitis of skin.
Am J Gastroenterol. 1996 Nov;91(11):2410-3.
6
Treatment of Crohn's disease at the turn of the century.
N Engl J Med. 1998 Aug 6;339(6):401-2. doi: 10.1056/NEJM199808063390610.
7
The clinical entity of orofacial Crohn's disease.
Q J Med. 1991 May;79(289):451-8.
8
[Primary oral manifestation of Crohn disease].
Ugeskr Laeger. 2002 Jun 17;164(25):3363-4.
9
Mesalazine-induced lupus.
Rev Rhum Engl Ed. 1997 Oct;64(10):586-8.
10
Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
Isr Med Assoc J. 2003 Dec;5(12):897-8.
Zotero 插件